Australians could soon have access to a daily Wegovy weight-loss pill, with approval expected before Christmas.

The tablet contains semaglutide, the same active ingredient used in the popular Wegovy injection.

Health experts say the pill could make obesity treatment easier for people who prefer tablets over weekly injections.

The medicine has already received approval in the United States and is attracting strong international demand.

Australian regulators are now reviewing the medication, with a decision expected by the end of the year.

If approved, the new pill could offer millions of Australians a more convenient option for long-term weight management.